drugset / Trial / NCT03706521
MRI Study to Evaluate the Safety and Efficacy of SM04690 for Knee Osteoarthritis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study was to evaluate the safety and efficacy of lorecivivint (LOR) injected in the target knee joint of moderately to severely symptomatic osteoarthritis (OA) subjects. Efficacy was primarily evaluated via magnetic resonance imaging (MRI).
Timeline
- Start
- 2019-03-11
- Primary completion
- 2020-07-22
- Completion
- 2020-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lorecivivint | Small molecule | 0.07 mg | Other |